Clinical trials
Completed Gram-Positive Bacterial Infections trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 3 |
| 2003 | 4 |
| 2004 | 2 |
| 2005 | 4 |
| 2006 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 34 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 4 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 4 |
| Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 3 |
| Cumberland Pharmaceuticals | 3 |
| Michael Hoelscher | 2 |
| Andrew Steer | 1 |
| Biomedical Advanced Research and Development Authority | 1 |
| Forest Laboratories | 1 |
| Hopital Lariboisière | 1 |
| Imperial College London | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gram-Positive Bacterial Infections | 34 |
| Bacterial Infections | 13 |
| Staphylococcal Infections | 4 |
| Abscess | 3 |
| Bacteremia | 3 |
| Cellulitis | 3 |
| Gram-Negative Bacterial Infections | 3 |
| Sepsis | 3 |
| Streptococcal Infections | 3 |
| Tuberculosis | 3 |
Trials
Showing 51 to 34 of 34. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.